Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Capital Employed (2019 - 2025)

AVITA Medical (RCEL) has disclosed Return on Capital Employed for 4 consecutive years, with 3.9% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 411.0% year-over-year to 3.9%, compared with a TTM value of 3.9% through Dec 2025, up 411.0%, and an annual FY2025 reading of 1.9%, down 173.0% over the prior year.
  • Return on Capital Employed was 3.9% for Q4 2025 at AVITA Medical, up from 1.7% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 3.9% in Q4 2025 and bottomed at 2.51% in Q2 2025.
  • Average Return on Capital Employed over 4 years is 0.19%, with a median of 0.2% recorded in 2023.
  • Peak annual rise in Return on Capital Employed hit 411bps in 2025, while the deepest fall reached -227bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.06% in 2022, then tumbled by -41bps to 0.09% in 2023, then crashed by -142bps to 0.22% in 2024, then soared by 1909bps to 3.9% in 2025.
  • Business Quant data shows Return on Capital Employed for RCEL at 3.9% in Q4 2025, 1.7% in Q3 2025, and 2.51% in Q2 2025.